Aemetis (NASDAQ:AMTX - Get Free Report)'s stock had its "buy" rating reissued by research analysts at HC Wainwright in a report released on Friday,Benzinga reports. They currently have a $28.00 price target on the specialty chemicals company's stock.
Separately, StockNews.com upgraded shares of Aemetis to a "sell" rating in a research report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $14.56.
Read Our Latest Stock Analysis on Aemetis
Aemetis Stock Performance
Shares of Aemetis stock traded down $0.07 during trading hours on Friday, reaching $1.97. The company's stock had a trading volume of 932,253 shares, compared to its average volume of 867,804. The company's 50 day simple moving average is $2.16 and its 200 day simple moving average is $2.67. Aemetis has a one year low of $1.50 and a one year high of $7.03. The stock has a market cap of $100.77 million, a P/E ratio of -0.87 and a beta of 1.48.
Institutional Trading of Aemetis
Several hedge funds have recently bought and sold shares of AMTX. FMR LLC lifted its position in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company's stock valued at $52,000 after purchasing an additional 9,137 shares during the last quarter. State Street Corp raised its position in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company's stock worth $1,608,000 after buying an additional 185,304 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of Aemetis during the 3rd quarter worth about $177,000. Barclays PLC raised its position in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock worth $109,000 after buying an additional 34,816 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company's stock worth $2,126,000 after buying an additional 66,031 shares in the last quarter. 27.02% of the stock is currently owned by institutional investors.
About Aemetis
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Featured Articles
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
